Plunkett Research Online: Celsion Corporation

CELSION CORPORATION (CLSN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Oncology drug development company.....

Celsion Corporation
Ticker: CLSN
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 609 896-9100
Fax: 609 896-2200
Address: 997 Lenox Drive
Suite 100
Lawrenceville, NJ 08648 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description

Michael Tardugno CEO/Director/President/Chairman of the Board
Jeffrey Church CFO/Executive VP/Secretary
See More
Oncology drug development company.....See More See More

Auditor: WithumSmith+Brown, PC
Legal Advisor: O'Melveny & Myers LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: